TY - JOUR AU - Sanmamed, M. F. AU - Chen, L. PY - 2018 DA - 2018// TI - A paradigm shift in cancer immunotherapy: from enhancement to normalization JO - Cell VL - 175 UR - https://doi.org/10.1016/j.cell.2018.09.035 DO - 10.1016/j.cell.2018.09.035 ID - Sanmamed2018 ER - TY - STD TI - Andrews LP, Yano H, Vignali DAA. Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups. Nat Immunol. 2019. https://doi.org/10.1038/s41590-019-0512-0. ID - ref2 ER - TY - JOUR AU - O'Donnell, J. S. AU - Long, G. V. AU - Scolyer, R. A. AU - Teng, M. W. AU - Smyth, M. J. PY - 2017 DA - 2017// TI - Resistance to PD1/PDL1 checkpoint inhibition JO - Cancer Treat Rev VL - 52 UR - https://doi.org/10.1016/j.ctrv.2016.11.007 DO - 10.1016/j.ctrv.2016.11.007 ID - O'Donnell2017 ER - TY - JOUR AU - Smyth, M. J. AU - Ngiow, S. F. AU - Ribas, A. AU - Teng, M. W. PY - 2016 DA - 2016// TI - Combination cancer immunotherapies tailored to the tumour microenvironment JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2015.209 DO - 10.1038/nrclinonc.2015.209 ID - Smyth2016 ER - TY - JOUR AU - Kon, E. AU - Benhar, I. PY - 2019 DA - 2019// TI - Immune checkpoint inhibitor combinations: current efforts and important aspects for success JO - Drug Resist Updat VL - 45 UR - https://doi.org/10.1016/j.drup.2019.07.004 DO - 10.1016/j.drup.2019.07.004 ID - Kon2019 ER - TY - JOUR AU - Zhou, X. -. M. AU - Li, W. -. Q. AU - Wu, Y. -. H. AU - Han, L. AU - Cao, X. -. G. AU - Yang, X. -. M. PY - 2018 DA - 2018// TI - Intrinsic expression of immune checkpoint molecule TIGIT could help tumor growth in vivo by suppressing the function of NK and CD8+ T cells JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.02821 DO - 10.3389/fimmu.2018.02821 ID - Zhou2018 ER - TY - STD TI - Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989; 56, 855–865. doi: doi.org/https://doi.org/10.1016/0092-8674(89)90690-9. ID - ref7 ER - TY - JOUR AU - Sloan, K. E. AU - Eustace, B. K. AU - Stewart, J. K. AU - Zehetmeier, C. AU - Torella, C. AU - Simeone, M. PY - 2004 DA - 2004// TI - CD155/PVR plays a key role in cell motility during tumor cell invasion and migration JO - BMC Cancer VL - 4 UR - https://doi.org/10.1186/1471-2407-4-73 DO - 10.1186/1471-2407-4-73 ID - Sloan2004 ER - TY - JOUR AU - Selinka, H. C. AU - Zibert, A. AU - Wimmer, E. PY - 1991 DA - 1991// TI - Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway JO - Proc Natl Acad Sci U S A VL - 88 UR - https://doi.org/10.1073/pnas.88.9.3598 DO - 10.1073/pnas.88.9.3598 ID - Selinka1991 ER - TY - JOUR AU - Bottino, C. AU - Castriconi, R. AU - Pende, D. AU - Rivera, P. AU - Nanni, M. AU - Carnemolla, B. PY - 2003 DA - 2003// TI - Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20030788 DO - 10.1084/jem.20030788 ID - Bottino2003 ER - TY - JOUR AU - Yu, X. AU - Harden, K. AU - Gonzalez, L. C. AU - Francesco, M. AU - Chiang, E. AU - Irving, B. PY - 2009 DA - 2009// TI - The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells JO - Nat Immunol VL - 10 UR - https://doi.org/10.1038/ni.1674 DO - 10.1038/ni.1674 ID - Yu2009 ER - TY - JOUR AU - Zheng, Q. AU - Wang, B. AU - Gao, J. AU - Xin, N. AU - Wang, W. AU - Song, X. PY - 2018 DA - 2018// TI - CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells JO - J Cell Mol Med VL - 22 UR - https://doi.org/10.1111/jcmm.13301 DO - 10.1111/jcmm.13301 ID - Zheng2018 ER - TY - JOUR AU - Wu, L. AU - Mao, L. AU - Liu, J. F. AU - Chen, L. AU - Yu, G. T. AU - Yang, L. L. PY - 2019 DA - 2019// TI - Blockade of TIGIT/CD155 signaling reverses T-cell exhaustion and enhances antitumor capability in head and neck squamous cell carcinoma JO - Cancer Immunol Res VL - 7 UR - https://doi.org/10.1158/2326-6066.CIR-18-0725 DO - 10.1158/2326-6066.CIR-18-0725 ID - Wu2019 ER - TY - JOUR AU - Inozume, T. AU - Yaguchi, T. AU - Furuta, J. AU - Harada, K. AU - Kawakami, Y. AU - Shimada, S. PY - 2016 DA - 2016// TI - Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase JO - J Invest Dermatol VL - 136 UR - https://doi.org/10.1038/jid.2015.404 DO - 10.1038/jid.2015.404 ID - Inozume2016 ER - TY - JOUR AU - He, W. L. AU - Zhang, H. AU - Han, F. AU - Chen, X. L. AU - Lin, R. AU - Wang, W. PY - 2017 DA - 2017// TI - CD155/TIGIT signaling regulates CD8+ T cell metabolism and promotes tumor progression in human gastric cancer JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.can-17-0381 DO - 10.1158/0008-5472.can-17-0381 ID - He2017 ER - TY - JOUR AU - Stengel, K. F. AU - Harden-Bowles, K. AU - Yu, X. AU - Rouge, L. AU - Yin, J. P. AU - Comps-Agrar, L. PY - 2012 DA - 2012// TI - Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1120606109 DO - 10.1073/pnas.1120606109 ID - Stengel2012 ER - TY - JOUR AU - Liu, S. AU - Zhang, H. AU - Li, M. AU - Hu, D. AU - Li, C. AU - Ge, B. PY - 2013 DA - 2013// TI - Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells JO - Cell Death Differ VL - 20 UR - https://doi.org/10.1038/cdd.2012.141 DO - 10.1038/cdd.2012.141 ID - Liu2013 ER - TY - JOUR AU - Johnston, R. J. AU - Comps-Agrar, L. AU - Hackney, J. AU - Yu, X. AU - Huseni, M. AU - Yang, Y. PY - 2014 DA - 2014// TI - The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function JO - Cancer Cell VL - 26 UR - https://doi.org/10.1016/j.ccell.2014.10.018 DO - 10.1016/j.ccell.2014.10.018 ID - Johnston2014 ER - TY - JOUR AU - Zhang, Q. AU - Bi, J. AU - Zheng, X. AU - Chen, Y. AU - Wang, H. AU - Wu, W. PY - 2018 DA - 2018// TI - Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity JO - Nat Immunol VL - 19 UR - https://doi.org/10.1038/s41590-018-0132-0 DO - 10.1038/s41590-018-0132-0 ID - Zhang2018 ER - TY - JOUR AU - Kurtulus, S. AU - Sakuishi, K. AU - Ngiow, S. F. AU - Joller, N. AU - Tan, D. J. AU - Teng, M. W. PY - 2015 DA - 2015// TI - TIGIT predominantly regulates the immune response via regulatory T cells JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/jci81187 DO - 10.1172/jci81187 ID - Kurtulus2015 ER - TY - JOUR AU - Zhuo, B. AU - Li, Y. AU - Gu, F. AU - Li, Z. AU - Sun, Q. AU - Shi, Y. PY - 2018 DA - 2018// TI - Overexpression of CD155 relates to metastasis and invasion in osteosarcoma JO - Oncol Lett VL - 15 UR - https://doi.org/10.3892/ol.2018.8228 DO - 10.3892/ol.2018.8228 ID - Zhuo2018 ER - TY - JOUR AU - Chang, H. N. AU - Liu, B. Y. AU - Qi, Y. K. AU - Zhou, Y. AU - Chen, Y. P. AU - Pan, K. M. PY - 2015 DA - 2015// TI - Blocking of the PD-1/PD-L1 interaction by a D-peptide antagonist for cancer immunotherapy JO - Angew Chem Int Ed Eng VL - 54 UR - https://doi.org/10.1002/anie.201506225 DO - 10.1002/anie.201506225 ID - Chang2015 ER - TY - JOUR AU - Zhai, W. AU - Zhou, X. AU - Wang, H. AU - Li, W. AU - Chen, G. AU - Sui, X. PY - 2020 DA - 2020// TI - A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8(+) T cell responses JO - Acta Pharm Sin B VL - 10 UR - https://doi.org/10.1016/j.apsb.2020.01.005 DO - 10.1016/j.apsb.2020.01.005 ID - Zhai2020 ER - TY - JOUR AU - Sasikumar, P. G. AU - Ramachandra, M. PY - 2018 DA - 2018// TI - Small-molecule immune checkpoint inhibitors targeting PD-1/PD-L1 and other emerging checkpoint pathways JO - BioDrugs VL - 32 UR - https://doi.org/10.1007/s40259-018-0303-4 DO - 10.1007/s40259-018-0303-4 ID - Sasikumar2018 ER - TY - JOUR AU - Adams, J. L. AU - Smothers, J. AU - Srinivasan, R. AU - Hoos, A. PY - 2015 DA - 2015// TI - Big opportunities for small molecules in immuno-oncology JO - Nat Rev Drug Discov VL - 14 UR - https://doi.org/10.1038/nrd4596 DO - 10.1038/nrd4596 ID - Adams2015 ER - TY - JOUR AU - Kerr, W. G. AU - Chisholm, J. D. PY - 2019 DA - 2019// TI - The next generation of immunotherapy for cancer: small molecules could make big waves JO - J Immunol VL - 202 UR - https://doi.org/10.4049/jimmunol.1800991 DO - 10.4049/jimmunol.1800991 ID - Kerr2019 ER - TY - JOUR AU - Chen, Y. AU - Bruyn, K. C. AU - Kirchmair, J. PY - 2017 DA - 2017// TI - Data resources for the computer-guided discovery of bioactive natural products JO - J Chem Inf Model VL - 57 UR - https://doi.org/10.1021/acs.jcim.7b00341 DO - 10.1021/acs.jcim.7b00341 ID - Chen2017 ER - TY - JOUR AU - Li, T. AU - Fan, J. AU - Wang, B. AU - Traugh, N. AU - Chen, Q. AU - Liu, J. S. PY - 2017 DA - 2017// TI - TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.can-17-0307 DO - 10.1158/0008-5472.can-17-0307 ID - Li2017 ER - TY - JOUR AU - Rhodes, D. R. AU - Kalyana-Sundaram, S. AU - Mahavisno, V. AU - Varambally, R. AU - Yu, J. AU - Briggs, B. B. PY - 2007 DA - 2007// TI - Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles JO - Neoplasia VL - 9 UR - https://doi.org/10.1593/neo.07112 DO - 10.1593/neo.07112 ID - Rhodes2007 ER - TY - BOOK AU - Zhai, W. AU - Zhou, X. AU - Du, J. AU - Gao, Y. PY - 2019 DA - 2019// TI - In vitro assay for the development of small molecule inhibitors targeting PD-1/PD-L1. Methods in Enzymology Academic Press ID - Zhai2019 ER - TY - JOUR AU - Luan, Y. AU - Chai, D. AU - Peng, J. AU - Ma, S. AU - Wang, M. AU - Ma, H. PY - 2016 DA - 2016// TI - A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity JO - Int Immunopharmacol VL - 31 UR - https://doi.org/10.1016/j.intimp.2015.12.039 DO - 10.1016/j.intimp.2015.12.039 ID - Luan2016 ER - TY - JOUR AU - Liang, Z. AU - Tian, Y. AU - Cai, W. AU - Weng, Z. AU - Li, Y. AU - Zhang, H. PY - 2017 DA - 2017// TI - High-affinity human PD-L1 variants attenuate the suppression of T cell activation JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.21729 DO - 10.18632/oncotarget.21729 ID - Liang2017 ER - TY - JOUR AU - Xu, Y. AU - Cui, G. AU - Jiang, Z. AU - Li, N. AU - Zhang, X. PY - 2019 DA - 2019// TI - Survival analysis with regard to PD-L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors JO - Oncol Lett VL - 17 UR - https://doi.org/10.3892/ol.2019.9910 DO - 10.3892/ol.2019.9910 ID - Xu2019 ER - TY - JOUR AU - Manieri, N. A. AU - Chiang, E. Y. AU - Grogan, J. L. PY - 2017 DA - 2017// TI - TIGIT: a key inhibitor of the Cancer immunity cycle JO - Trends Immunol VL - 38 UR - https://doi.org/10.1016/j.it.2016.10.002 DO - 10.1016/j.it.2016.10.002 ID - Manieri2017 ER - TY - JOUR AU - Bowers, J. R. AU - Readler, J. M. AU - Sharma, P. AU - Excoffon, K. PY - 2017 DA - 2017// TI - Poliovirus receptor: more than a simple viral receptor JO - Virus Res VL - 242 UR - https://doi.org/10.1016/j.virusres.2017.09.001 DO - 10.1016/j.virusres.2017.09.001 ID - Bowers2017 ER - TY - JOUR AU - Peng, J. AU - Xiao, Y. AU - Li, W. AU - Yang, Q. AU - Tan, L. AU - Jia, Y. PY - 2018 DA - 2018// TI - Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy JO - Adv Sci (Weinh) VL - 5 UR - https://doi.org/10.1002/advs.201700891 DO - 10.1002/advs.201700891 ID - Peng2018 ER - TY - JOUR AU - Krashin, E. AU - Piekielko-Witkowska, A. AU - Ellis, M. AU - Ashur-Fabian, O. PY - 2019 DA - 2019// TI - Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies JO - Front Endocrinol (Lausanne) VL - 10 UR - https://doi.org/10.3389/fendo.2019.00059 DO - 10.3389/fendo.2019.00059 ID - Krashin2019 ER - TY - JOUR AU - Funazo, T. Y. AU - Nomizo, T. AU - Ozasa, H. AU - Tsuji, T. AU - Yasuda, Y. AU - Yoshida, H. PY - 2019 DA - 2019// TI - Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-53327-7 DO - 10.1038/s41598-019-53327-7 ID - Funazo2019 ER - TY - JOUR AU - Ma, B. AU - Duan, X. AU - Zhou, Q. AU - Liu, J. AU - Yang, X. AU - Zhang, D. PY - 2019 DA - 2019// TI - Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway JO - J Cell Mol Med VL - 23 UR - https://doi.org/10.1111/jcmm.14332 DO - 10.1111/jcmm.14332 ID - Ma2019 ER - TY - JOUR AU - Fang, L. AU - Zhao, F. AU - Iwanowycz, S. AU - Wang, J. AU - Yin, S. AU - Wang, Y. PY - 2019 DA - 2019// TI - Anticancer activity of emodin is associated with downregulation of CD155 JO - Int Immunopharmacol VL - 75 UR - https://doi.org/10.1016/j.intimp.2019.105763 DO - 10.1016/j.intimp.2019.105763 ID - Fang2019 ER -